Yangbo Feng
Xi'an, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Correction: Molecular typing of stage IB non-small-cell lung cancer for precision medicine.
Journal: Frontiers in oncology
Published: July 16, 2026
Molecular typing of stage IB non-small-cell lung cancer for precision medicine.
Journal: Frontiers in oncology
Published: April 02, 2025
Correction to: Combined pembrolizumab and bevacizumab therapy effectively inhibits non-small-cell lung cancer growth and prevents postoperative recurrence and metastasis in humanized mouse model.
Journal: Cancer immunology, immunotherapy : CII
Published: December 26, 2022
Combined pembrolizumab and bevacizumab therapy effectively inhibits non-small-cell lung cancer growth and prevents postoperative recurrence and metastasis in humanized mouse model.
Journal: Cancer immunology, immunotherapy : CII
Published: June 16, 2022
TFAP2A potentiates lung adenocarcinoma metastasis by a novel miR-16 family/TFAP2A/PSG9/TGF-β signaling pathway.
Journal: Cell death & disease
Published: December 30, 2020
Inhibition of LDH-A by Oxamate Enhances the Efficacy of Anti-PD-1 Treatment in an NSCLC Humanized Mouse Model.
Journal: Frontiers in oncology
Published: November 23, 2020
Gene expression-based clinical predictions in lung adenocarcinoma.
Journal: Aging
Published: May 16, 2020
Identifying prognostic biomarkers of non-small cell lung cancer by transcriptome analysis.
Journal: Cancer biomarkers : section A of Disease markers
Published: February 22, 2020
A gene-based survival score for lung adenocarcinoma by multiple transcriptional datasets analysis.
Journal: BMC cancer
Published: February 15, 2020
Lactate dehydrogenase A: A key player in carcinogenesis and potential target in cancer therapy.
Journal: Cancer medicine
Published: July 30, 2018
Flexibility in metabolism bestows tenacious viability on cancer.
Journal: Life sciences
Published: June 07, 2018
Showing 1-11 of 11
Last Updated: 09/26/2026